Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing Safety and Immunogenicity of Hualan's Inactivated Influenza Vaccine
NCT01568788Phase 4Completed
- Sponsor
- Hualan Biological Engineering Inc.
- Start
- Dec 2008
- Primary completion
- Jan 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of Fluzone Trivalent in influenza (3 arms), sponsored by Hualan Biological Engineering Inc. Primary endpoint: Number of subjects with adverse reactions at 28 days. Started Dec 2008; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01568788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01568788.